Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Thrombosis Research|December 1, 2009
The role of prophylaxis in the management of von Willebrand disease: today and tomorrowThomas AbshireSeminars in Hematology|July 17, 2008
Safety update on recombinant factor VIIa in the treatment of congenital and acquired hemophiliaThomas AbshireThrombosis Research|March 21, 2006
The von Willebrand disease prophylaxis network (vWD PN): exploring a treatment conceptErik Berntorp, Thomas Abshire, Current Opinion in Hematology|August 13, 2003
Lupus anticoagulants in childrenMichael Briones, Thomas AbshireClinical Advances in Hematology & Oncology : H&O|September 16, 2005
The new albumin-free recombinant factor VIII concentrates for treatment of hemophilia: do they represent an actual incremental improvement?Cassandra D Josephson, Thomas AbshireJournal of Pediatric Hematology/Oncology|July 27, 2013
Treatment of relapsed precursor-B acute lymphoblastic leukemia with intensive chemotherapy: POG (Pediatric Oncology Group) study 9411 (SIMAL 9)Michael E Kelly, Xiaomin Lu, Meenakshi Devidas, et al.Journal of Thrombosis and Haemostasis : JTH|July 3, 2022
Longitudinal bleeding assessment in von Willebrand disease utilizing an interim bleeding scoreMichelle Lavin, Pamela Christopherson, Julie Grabell, et al.Blood|February 24, 2006
Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant ResearchMary Eapen, Elizabeth Raetz, Mei-Jie Zhang, et al.Pageof 2